SWS Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SWS Partners's AMGN Position: Q2 2026 in Review
SWS Partners increased its Amgen (AMGN) stake by 0.65% in Q2 2026, buying an estimated $2.05K and bringing the position to 928 shares worth $336K. The position accounts for 0.07% of the portfolio, ranked #100.
SWS Partners first reported a position in AMGN in Q4 2017 and has held it in 15 quarters since. 1,625 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SWS Partners held 928 shares of Amgen worth $336K as of Q2 2026.
- SWS Partners bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
- Amgen made up 0.07% of SWS Partners's portfolio in Q2 2026, its #100 holding.
- SWS Partners first reported a position in Amgen in Q4 2017 and has held it in 15 quarters since.
- 1,625 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SWS Partners's 13F filing for Q2 2026, filed 3 Aug 2026.